← Leaderboards
Bradford B Worrall
University Of Virginia
$7,974,253
Attributed
$13,453,219
Total exposure
7
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $4.9M · FY2005–25$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$22,816,135 · 8
By mechanism
U01$13,918,645 · 3
KL2$3,925,406 · 1
U24$2,430,038 · 1
R01$1,232,730 · 1
K08$840,535 · 1
R21$468,781 · 1
Top collaborators
- Amie Hsia8 shared
- Jason Papin5 shared
- Michele M Sale5 shared
- Barbara S Bregman4 shared
- George Howard4 shared
- Steven J Kittner4 shared
- James F Meschia4 shared
- Bruce M Psaty4 shared
Most similar at University Of Virginia
Same institution · by research overlap
- Li Li$10,636,659
- Fang-Chi Hsu$846,291
Others in their field
Top investigators on “Innovation”
- David R. Weir · University Of Michigan At Ann Arbor$382,307,654
- Eric Jeffrey Topol · Cleveland Clinic Lerner Col/Med-Cwru$319,874,172
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$311,654,401
- Richard A Gibbs · Baylor College Of Medicine$300,634,418
- Gerald T Nepom · Benaroya Research Inst At Virginia Mason$298,740,071
- Judith S. Currier · University Of California Los Angeles$271,752,220
Research focus
InnovationVirginiaUniversitiesResourcesGeneticStrokeNational Institute Of Neurological Disorders And StrokeResearch PersonnelProgramsPlayPreventionTrainingMentorsBlood VesselsFundingCareer DevelopmentClinical ResearchBaseCollaborationsParticipantAdultBiological MarkersPhenotypeInstitution
Grant awards (34)
Shared and novel contributors to risk of stroke and stroke recurrence in a multiethnic population â the role of social determinants of health, genetics, and epigenetics$565,495
R01 · FY2025 · NS · contact PI
Stroke Central Atlantic Network for Research (SCANR)$374,782
U24 · FY2025 · NS
Shared and novel contributors to risk of stroke and stroke recurrence in a multiethnic population â the role of social determinants of health, genetics, and epigenetics$667,235
R01 · FY2024 · NS · contact PI
Stroke Central Atlantic Network for Research (SCANR)$450,274
U24 · FY2024 · NS
Institutional Career Development Core$638,696
KL2 · FY2023 · TR
Stroke Central Atlantic Network for Research (SCANR)$37,287
U24 · FY2023 · NS
Institutional Career Development Core$923,222
KL2 · FY2022 · TR
Stroke Central Atlantic Network for Research (SCANR)$300,358
U24 · FY2022 · NS
Institutional Career Development Core$924,249
KL2 · FY2021 · TR
Stroke Central Atlantic Network for Research (SCANR)$303,296
U24 · FY2021 · NS
Institutional Career Development Core$906,409
KL2 · FY2020 · TR
Stroke Central Atlantic Network for Research (SCANR)$312,621
U24 · FY2020 · NS
Institutional Career Development Core$532,830
KL2 · FY2019 · TR
Stroke Central Atlantic Network for Research (SCANR)$317,967
U24 · FY2019 · NS
Gastrointestinal Microbiome and Stroke Outcomes Network (GEMSTONE)$204,044
R21 · FY2019 · NS · contact PI
Stroke Central Atlantic Network for Research (SCANR)$333,453
U24 · FY2018 · NS
Gastrointestinal Microbiome and Stroke Outcomes Network (GEMSTONE)$264,737
R21 · FY2018 · NS · contact PI
The NINDS International Stroke Genetics Consortium Study$1,202,540
U01 · FY2013 · NS
Phenotype core - The NINDS International Stroke Genetics Consortium Study$687,278
U01 · FY2013 · NS · contact PI
The NINDS International Stroke Genetics Consortium Study$1,440,297
U01 · FY2012 · NS
Phenotype core - The NINDS International Stroke Genetics Consortium Study$824,421
U01 · FY2012 · NS · contact PI
The NINDS International Stroke Genetics Consortium Study$3,029,472
U01 · FY2011 · NS
Pharmacogenomic studies in VISP: results & implications for clinical trial design$698,373
U01 · FY2011 · HG
Phenotype core - The NINDS International Stroke Genetics Consortium Study$544,930
U01 · FY2011 · NS · contact PI
Pharmacogenomic studies in VISP: results & implications for clinical trial design$146,300
U01 · FY2011 · HG
The NINDS International Stroke Genetics Consortium Study$3,690,607
U01 · FY2010 · NS
Phenotype core - The NINDS International Stroke Genetics Consortium Study$615,002
U01 · FY2010 · NS · contact PI
Pharmacogenomic studies in VISP: results & implications for clinical trial design$614,434
U01 · FY2010 · HG
Pharmacogenomic studies in VISP: results & implications for clinical trial design$424,991
U01 · FY2009 · HG
Cerebrovascular Atherosclerosis: Genes & Gene Expression$168,107
K08 · FY2009 · NS · contact PI
Cerebrovascular Atherosclerosis: Genes & Gene Expression$168,107
K08 · FY2008 · NS · contact PI
Cerebrovascular Atherosclerosis: Genes & Gene Expression$168,107
K08 · FY2007 · NS · contact PI
Cerebrovascular Atherosclerosis: Genes & Gene Expression$168,107
K08 · FY2006 · NS · contact PI
Cerebrovascular Atherosclerosis: Genes &Gene Expression$168,107
K08 · FY2005 · NS